MSN Laboratories Gets CDSCO Panel Nod To study Brexpiprazole Tablets Dr. Divya Colin2 May 2025 6:00 PM ISTNew Delhi: Considering the bioequivalence study of Brexpiprazole Tablets 0.25mg /0.5 mg/1mg/2mg/3mg/4mg, the Subject Expert Committee (SEC) functional...
MSN Laboratories Gets CDSCO Panel Nod To Manufacture, Market Lurasidone Tablets 60 mg, 120 mg for Schizophrenia Dr. Divya Colin28 April 2025 6:00 PM ISTNew Delhi: MSN Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Six Pharma Suppliers Blacklisted in Five Years for Failing Quality Standards: MoS Anupriya Patel Farhat Nasim4 Dec 2024 5:00 PM ISTNew Delhi: Over the last five years, six pharmaceutical suppliers have been blacklisted for providing substandard medicines to Jan Aushadhi Kendras...
MSN Laboratories Gets CDSCO Panel nod to Manufacture, Market Tolvaptan Tablets 7.5 mg Dr. Divya Colin23 Nov 2024 5:45 PM ISTNew Delhi: Considering the published data on efficacy studies of Tolvaptan Tablets 7.5 mg, the Subject Expert Committee (SEC) functional under the...
Dr Reddy's, Aurobindo Pharma, 4 Others Ink MoUs for Rs 5,260 Crore Pharma City Investment Farhat Nasim23 Nov 2024 1:45 PM ISTThe companies have committed to invest over Rs 5,260 crore, which is expected to create 12,490 job opportunities in the pharma sector
MSN Laboratories Gets CDSCO Panel Nod To Manufacture, Market Ferumoxytol Injection Dr. Divya Colin10 July 2024 6:00 PM ISTNew Delhi: Accepting the pharmacokinetics study data and the published literature on global clinical trial data involving 112 Indian patients, the...
Submit Data on Paracetamol-Tapentadol Combination: CDSCO Panel tells MSN Laboratories Dr. Divya Colin12 May 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by MSN Laboratories for the fixed-dose combination (FDC) drug Paracetamol plus Tapentadol...
CDSCO Panel Rejects MSN Laboratories Proposal For Combikit of Silodosin Capsules plus Mirabegron Dr. Divya Colin15 Oct 2023 6:30 PM ISTNew Delhi: Highlighting that there is no unmet need for the proposed Combi kit of Silodosin Capsules 8mg/8mg plus Mirabegron extended released (ER)...
MSN Lab gets CDSCO Panel Nod To Manufacture, Market Combi kit for Macitentan 10mg plus Tadalafil 20mg Dr. Divya Colin9 Sept 2023 6:00 PM ISTNew Delhi: Granting approval for Phase III clinical trial and bioequivalence (BE) study wavier, the Subject Expert Committee (SEC) functional under...
submit pool data along with Indian patient data: CDSCO panel Tells MSN Laboratories Over Vigabatrin Tablets Dr. Divya Colin30 Aug 2023 6:00 PM ISTNew Delhi: In response to the proposal presented by the drug major MSN Laboratories to manufacture and market the antiepileptic drug Vigabatrin, the...
MSN Labs gets CDSCO panel nod to manufacture, market Tofacitnib Oral Solution Dr. Divya Colin22 Jun 2023 4:40 PM ISTNew Delhi: Granting waivers for local clinical trials and bioavailability/bioequivalence (BA/BE) studies, the Subject Expert Committee (SEC)...
HC restrains pharma companies from infringing Boehringer Ingelheim diabetes drug Linagliptin Susmita Roy8 Jun 2022 4:04 PM ISTNew Delhi: In a major relief to pharmaceuticals major Boehringer Ingelheim, the High Court has restrained four domestic pharma companies namely,...
